| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A portion of amino acids 147-175 from the human protein was used as the immunogen for the GREM1 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
GREM1 Antibody / Gremlin 1 is an antibody targeting GREM1, raised in Rabbit for protein detection and localization studies where these specifications are required.
Key elements and design rationale
- Target: GREM1.
- Antibody identity: Polyclonal (rabbit origin); Rabbit Ig.
- Conjugate/label: Unconjugated (affects detection chemistry and multiplex compatibility).
- Format: Purified.
- Species reactivity: Human, Mouse.
- Listed applications: WB, IHC-P (refer to on-page specifications for application-specific guidance).
Biological background
GREM1, also referred to as Gremlin 1, is a protein that plays a crucial role in a variety of biological processes, ranging from embryonic development to cancer progression. This multifunctional protein is a member of the BMP (Bone Morphogenetic Protein) antagonist family and is known for its ability to regulate cell growth, differentiation, and survival. One of the most intriguing aspects of GREM1 is its role in embryonic development. Studies have shown that this protein is essential for proper development of various tissues and organs, such as the lung, kidney, and limb. Additionally, GREM1 has been implicated in the formation of certain structures in the developing embryo, highlighting its importance in shaping the body's overall architecture. In addition to its role in embryonic development, GREM1 has also been linked to various diseases, particularly cancer. Research has shown that abnormal levels of Gremlin 1 are associated with tumor growth, invasion, and metastasis in several types of cancer, including colorectal, ovarian, and pancreatic cancer. This suggests that targeting GREM1 could potentially be a novel strategy for combating cancer progression. GREM1 has recently gained attention for its potential as a therapeutic target in certain diseases.
Research relevance and current trends
- Comparative expression profiling across cell types, tissues, or perturbations (e.g., drug treatment, genetic editing, or differentiation).
- Subcellular localization and trafficking studies, including co-localization with pathway markers in microscopy-based assays.
- Integration of protein-level measurements with transcriptomics or proteomics to relate abundance to regulation and phenotype.
Common research applications
- Western blotting: researchers commonly compare relative signal levels across conditions and use appropriate negative/positive controls for interpretation.
- Immunohistochemistry: researchers commonly compare relative signal levels across conditions and use appropriate negative/positive controls for interpretation.
Interpretation should account for antibody-dependent factors such as epitope accessibility, isoforms, and sample preparation differences across workflows.
Notes for experimental interpretation
- Isoforms and PTMs: many targets have multiple isoforms and post-translational modifications that can shift apparent signal or localization; interpret bands/signals accordingly.
- Epitope context: binding can depend on protein conformation and sample processing; region information in the title/immunogen can help anticipate what may be detected.
- Species differences: predicted or validated reactivity may vary by ortholog sequence and sample context; confirm in your model system.
- Control concepts: include negative controls (no-primary/isotype), and where possible genetic controls (KO/KD) or independent antibodies to strengthen conclusions.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
